证券代码：300967 证券简称：晓鸣股份 公告编号：2023-138 宁夏晓鸣农牧股份有限公司 关于召开 2023 年第三次临时股东大会的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 宁夏晓鸣农牧股份有限公司（以下简称"公司"）第四届董事会第二十九次 会议审议通过了《关于提议召开公司 2023 年第三次临时股东大会的议案》，决 定于 2023 年 9 月 15 日（星期五）召开公司 2023 年第三次临时股东大会，审议 公司第四届董事会第二十九次会议、第四届监事会第二十一次会议提交的相关议 案，公司 2023 年 8 月 31 日于巨潮资讯网（http://www.cninfo.com.cn）披露了 《关于召开 2023 年第三次临时股东大会的通知》（公告编号：2023-133），现 将本次股东大会的有关事项提示公告如下： 一、 召开会议的基本情况 1、股东大会届次：2023 年第三次临时股东大会 2、股东大会的召集人：公司董事会 3、会议召开的合法、合规性：经公司第四届董事会第二十九次会议审议通 过，决定召开本次股东大会，召集程序符合有关法律 ...

证券代码：300967 证券简称：晓鸣股份 公告编号：2023-136 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 宁夏晓鸣农牧股份有限公司（以下简称"公司"）第四届监事会任期即将届 满，为保证公司监事会的正常运作，根据《中华人民共和国公司法》《深圳证券 交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号— —创业板上市公司规范运作》等法律、法规、规范性文件及《公司章程》的有关 规定，公司监事会将按照相关法律程序进行换届选举。公司第五届监事会由 3 名 监事组成，其中非职工代表监事 2 名，职工代表监事 1 名。职工代表监事由公司 职工代表大会选举产生。 公司于 2023 年 9 月 9 日召开了职工代表大会，经与会职工代表审议，一致 同意选举王忠贤先生为公司第五届监事会职工代表监事（简历详见附件）。王忠 贤先生将与公司股东大会选举产生的两名非职工代表监事共同组成公司第五届 监事会，任期将与经股东大会选举产生的非职工代表监事一致，自股东大会审议 通过非职工代表监事人选之日起三年。公司第五届监事会换届选举完成后，职工 代表监事的比例不低 ...

证券代码：300967 证券简称：晓鸣股份 公告编号：2023-135 宁夏晓鸣农牧股份有限公司 2023 年 8 月鸡产品销售情况简报 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、2023 年 8 月鸡产品销售情况 宁夏晓鸣农牧股份有限公司（以下简称"公司"）2023 年 8 月销售鸡产品 1,910.47 万羽，销售收入 5,062.29 万元，环比变动分别为-0.01%、29.71%，同 比变动分别为 13.69%、10.25%。 二、原因说明 2023 年 8 月，雏鸡整体市场需求及销售均价较上月有所改善，公司本月商 品代雏鸡销售数量与上月持平，营收较上月有较大幅度增长。 三、特别提示 1、上述财务数据均未经审计，可能与公司定期报告披露的数据存在一定差 异，敬请广大投资者谨慎决策，注意投资风险。 2、上述披露仅包含公司鸡产品销售情况，不包含其他业务。 3、公司指定的信息披露媒体为《证券时报》、《中国证券报》、《上海证 券报》、《证券日报》、《经济参考报》以及巨潮资讯网（www.cninfo.com.cn）， 公司所有信息均以公司在上述媒体刊登的 ...

Financial Performance - The company's gross profit margin for the past three years was 21.30%, 22.17%, and 12.71%, with net profits of 50.25 million, 81.85 million, and 7.32 million respectively, indicating a fluctuating trend due to upstream raw material price volatility and industry cycle fluctuations [9]. - The company has experienced a decline in net profit, attributed to rising costs and reduced demand from downstream customers, which may lead to increased sales difficulties and profit declines [9][11]. - The company's revenue for the first half of 2023 reached ¥457,596,230.88, representing a 16.92% increase compared to ¥391,372,581.22 in the same period last year [38]. - The net profit attributable to shareholders was -¥35,922,812.58, a significant decline of 269.26% from ¥21,223,563.08 in the previous year [38]. - The company's gross profit margin was 9.20%, down 4.03 percentage points from the previous year [73]. - The revenue from chicken sales was ¥380,589,732.70, with a gross margin of 6.17%, reflecting a decrease of 55.10% in gross margin compared to the previous year [128]. - The company reported a significant increase in financial expenses, which rose by 304.01% to ¥10,709,893.25, primarily due to increased interest expenses [125]. Market Conditions and Risks - The prices of corn and soybean meal, which constitute a significant portion of the feed, have remained high, leading to increased production costs and decreased gross margins, adversely affecting the company's operating performance [6]. - The company faces significant risks from avian diseases, which can lead to increased costs and reduced consumer demand for poultry products [4][5]. - The domestic demand for commodity chicks remains stable at around 1.1 billion annually, but the industry faces risks of overcapacity if sales and management capabilities do not keep pace with production expansion [12]. - The company acknowledges the cyclical nature of the egg-laying industry, which can lead to decreased demand and lower product prices during downturns [11]. - The company is exposed to price fluctuation risks, particularly in feed raw materials like corn and soybean meal, which could increase production costs and reduce profit margins [155]. Operational Strategies - The company emphasizes the importance of risk awareness regarding future plans and projections, urging investors to consider potential impacts on performance [3]. - The company operates four high-standard ecological breeding bases and has established 32 parent generation breeding farms across various regions [48]. - The company employs a "centralized breeding, decentralized hatching" model to enhance biosecurity and product quality [51]. - The company has established a long-term strategic partnership with the global breeding company Hy-Line for the procurement of grandparent generation chicks [54]. - The company has established a comprehensive internal control system for procurement, focusing on the market trends of raw materials and effectively managing procurement risks [55]. Research and Development - The company has filed for 2 patents and received authorization for 2 patents during the reporting period, enhancing its technological capabilities [78]. - The company has built partnerships with high-level research institutions to support innovation in its business model, including the establishment of the Ningxia Egg Chicken Industry Research Institute [101]. - The company is developing various projects related to disease prevention and control, nutrition, and low-carbon technologies in poultry farming [120][121]. - The company has established a comprehensive technology research institute, focusing on breeding, disease control, and green farming technologies, enhancing its competitive advantage in the egg chicken industry [197]. Biosecurity and Animal Welfare - The company has established a robust biosecurity system, with no major infectious diseases reported since its inception [84]. - The company has achieved national-level certifications for biosecurity, including being the only enterprise in the egg-laying industry to pass the disease-free zone assessment [91]. - The company has implemented a "full entry, full exit" biosecurity operation model, effectively preventing disease and rodent transmission [88]. - The company has received recognition for its contributions to animal welfare, including the "2018 Animal Welfare Breeding Gold Egg Award" from the World Farm Animal Welfare Association [93]. - The company has participated in drafting the "Farm Animal Welfare Requirements - Laying Hens" standard, promoting animal welfare awareness in China [193]. Corporate Governance and Social Responsibility - The company has established a standardized investor relations management process to enhance communication with investors and ensure accurate information dissemination [182]. - The company actively participates in social responsibility initiatives and community development, emphasizing environmental friendliness and resource conservation [177]. - The company has established a women's federation within its labor union to promote gender equality and protect women's rights [185]. - The company donated 435,000 chicks worth approximately 188,315.65 RMB to support poverty alleviation and rural revitalization efforts in Lankao County [188]. - The company was awarded the title of "Model Enterprise for Farm Animal Welfare" by the China Agricultural International Cooperation Promotion Association on June 27, 2023 [194].

| 证券代码：300967 | 证券简称：晓鸣股份 公告编号：2023-113 | | --- | --- | | 债券代码：123189 | 债券简称：晓鸣转债 | 宁夏晓鸣农牧股份有限公司 关于更换首次公开发行股票并在创业板上市项目及向不特定对象发 华西证券作为本公司首次公开发行股票并在创业板上市项目（以下简称"首 发项目"）及向不特定对象发行可转换公司债券项目（以下简称"可转债项目"） 的保荐机构，原委派杜国文先生、尹玉堂先生作为本公司首发项目及可转债项目 的持续督导保荐代表人，其中首发项目持续督导期至 2024 年 12 月 31 日。因尹 玉堂先生工作变动，不能再担任本公司首发项目及可转债项目持续督导的保荐代 表人，为保证持续督导工作的有序进行，华西证券指派周曼女士接替尹玉堂先生 履行本公司首发项目及可转债项目的持续督导工作。本次变更完成后，本公司首 发项目及可转债项目持续督导的保荐代表人为杜国文先生、周曼女士。 公司董事会对尹玉堂先生在公司持续督导期间所做的工作表示衷心感谢！ 特此公告。 宁夏晓鸣农牧股份有限公司董事会 2023 年 8 月 16 日 周曼女士简历如下： 行可转换公司债券项目持续督 ...

证券代码：300967 证券简称：晓鸣股份 公告编号：2023-112 二、原因说明 2023 年 7 月上旬市场延续上月行情，养殖单位补栏意愿偏弱，雏鸡需求及 价格未出现明显改善，中旬后鸡蛋和淘汰鸡价格上涨，雏鸡需求好转，但饲料成 本提升，养殖单位补栏意愿好转有限，雏鸡需求及价格仍处于相对低位。为应对 现阶段市场形势，公司适度优化产能结构，导致公司 7 月雏鸡生产量减少，加之 市场价格尚在低位震荡，本月商品代雏鸡销售数量、营收较上月均有一定程度下 降。 三、特别提示 1、上述财务数据均未经审计，可能与公司定期报告披露的数据存在一定差 异，敬请广大投资者谨慎决策，注意投资风险。 2、上述披露仅包含公司鸡产品销售情况，不包含其他业务。 3、公司指定的信息披露媒体为《证券时报》、《中国证券报》、《上海证 券报》、《证券日报》、《经济参考报》以及巨潮资讯网（www.cninfo.com.cn）， 宁夏晓鸣农牧股份有限公司 2023 年 7 月鸡产品销售情况简报 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、2023 年 7 月鸡产品销售情况 宁夏晓鸣农牧股份有 ...

证券代码： 300967 证券简称：晓鸣股份 宁夏晓鸣农牧股份有限公司 投资者关系活动记录表 编号：2023-002 | | □特定对象调研 分析师会议 □ | | | | | --- | --- | --- | --- | --- | | 投资者关系活动 | 业绩说明会 媒体采访  | □ | | | | 类别 | 新闻发布会 □ 路演活动 | □ | | | | | 现场参观 | □ | | | | | 其他 （请文字说明其他活动内容） | □ | | | | 形式 | 网上 □现场  □电话会议 | | | | | 参与单位名称及 人员姓名 | 投资者网上提问 | | | | | 时间 | 2023 年 5 月 11 (周四) 下午 14:00~17:00 | | 日 | | | 地点 | 公司通过全景网"投资者关系互动平台"（https://ir.p5w.net） | | | | | | 采用网络远程的方式召开业绩说明会 | | | | | 上市公司接待人 | 1、副总经理/董事会秘书：杜建峰 | | | | | | 2、财务总监：孙灵芝 | | | | | | 3、独立董事：张文君 | | | ...

Financial Performance - The company's revenue for Q1 2023 was CNY 211,447,555.87, representing a 12.36% increase compared to CNY 188,184,810.50 in the same period last year[5] - The net profit attributable to shareholders was CNY -11,101,307.26, a decrease of 181.36% from CNY 13,643,919.32 in the previous year[5] - Total operating revenue for Q1 2023 reached CNY 211,447,555.87, an increase of 12.0% compared to CNY 188,184,810.50 in Q1 2022[18] - Net profit for Q1 2023 was a loss of CNY 11,101,307.26, compared to a profit of CNY 13,643,919.32 in Q1 2022, indicating a significant decline[20] - Total operating costs for Q1 2023 were CNY 210,465,304.13, up 15.9% from CNY 181,234,019.71 in the same period last year[18] Cash Flow - The net cash flow from operating activities increased by 77.97% to CNY 39,677,247.46, up from CNY 22,294,117.92 in the same period last year[5] - The net cash flow from operating activities for Q1 2023 was CNY 39,677,247.46, an increase of 78.3% compared to CNY 22,294,117.92 in the same period last year[21] - Cash received from sales of goods and services amounted to CNY 238,645,887.54, up from CNY 182,929,329.85, reflecting a growth of 30.6% year-over-year[21] - The net cash flow from investing activities was -CNY 53,316,814.80, an improvement from -CNY 124,129,965.58 in the previous year[23] - Cash flow from financing activities generated a net inflow of CNY 50,189,388.72, compared to CNY 53,478,989.31 in the same quarter last year[23] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,485,344,875.59, reflecting a 2.20% increase from CNY 1,453,410,688.76 at the end of the previous year[5] - Total liabilities increased to CNY 697,419,530.17 in Q1 2023, compared to CNY 655,037,680.09 in Q1 2022, reflecting a rise of 6.4%[17] - The company's total liabilities increased, with contract liabilities rising by 63.24% due to increased product sales and prepayments[9] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 18,226, with the largest shareholder holding 42.14% of the shares[10] - The company has a diverse shareholder base, with the top ten shareholders holding a total of 42,000,000 shares, indicating strong institutional interest[11] Financial Expenses - Financial expenses surged by 171.29%, primarily due to increased bank loans and reduced capitalization of interest on projects[9] - The company reported a significant increase in financial expenses, totaling CNY 4,156,018.69 in Q1 2023, compared to CNY 1,531,970.19 in the previous year[18] Research and Development - Research and development expenses for Q1 2023 were CNY 4,111,012.56, down from CNY 5,436,094.83 in Q1 2022, indicating a reduction in investment in innovation[18] - The company is focused on expanding its market presence and enhancing its product offerings through ongoing research and development initiatives[12] Regulatory Engagement - The company is in the process of issuing convertible bonds, with the application approved by the China Securities Regulatory Commission on February 16, 2023[13] - The company has received inquiries from the Shenzhen Stock Exchange regarding its convertible bond issuance, indicating ongoing regulatory engagement[12] Other Financial Metrics - The company's basic and diluted earnings per share were both CNY -0.058, a decline of 179.45% from CNY 0.073 in the previous year[5] - The total equity attributable to shareholders decreased to CNY 787,925,345.42 in Q1 2023 from CNY 798,373,008.67 in Q1 2022, reflecting a decline of 1.8%[17] - The company reported accounts receivable of ¥20,170,819.81, slightly down from ¥20,203,158.40, showing a minor decrease of about 0.16%[15] - Prepayments increased to ¥6,766,876.41 from ¥4,000,618.98, marking a significant rise of approximately 69%[15] - The company experienced a 44.11% decrease in construction in progress, attributed to the completion of several projects, including the Hongshibao Smart Agriculture Industrial Demonstration Park[8]

Financial Performance - The company's gross profit margin decreased to 12.71% in 2022 from 22.17% in 2021, and net profit fell to 7.32 million from 81.85 million in the previous year[12]. - The company's operating revenue for 2022 was ¥785,510,490.19, an increase of 8.57% compared to ¥714,367,715.43 in 2021[36]. - The net profit attributable to shareholders decreased by 91.05% to ¥7,323,074.09 from ¥81,845,580.77 in the previous year[36]. - The net cash flow from operating activities was ¥107,460,910.07, down 38.76% from ¥175,482,675.16 in 2021[36]. - The total assets at the end of 2022 reached ¥1,453,410,688.76, representing a 25.14% increase from ¥1,161,422,423.76 in 2021[36]. - The company's basic earnings per share dropped by 91.67% to ¥0.04 from ¥0.48 in 2021[36]. - The net profit after deducting non-recurring gains and losses was ¥7,870,143.58, a decrease of 87.83% compared to ¥64,673,525.36 in 2021[36]. - The total equity attributable to shareholders decreased by 3.27% to ¥798,373,008.67 from ¥825,368,086.79 in 2021[37]. - The company reported a significant decline in quarterly net profit, with the fourth quarter showing a loss of ¥10,556,681.99[39]. - The company recognized government subsidies amounting to ¥16,915,052.95 in 2022, down from ¥19,678,228.05 in 2021[42]. Market Position and Sales - The company sold approximately 199 million chicks in 2022, capturing a market share of about 18%[15]. - The company holds approximately 18% market share in the domestic market for commercial broiler chicks in 2022, positioning itself among the industry leaders[94]. - The average selling price of chicks was 3.19 yuan per chick, a decrease of 0.23 yuan per chick compared to the previous year[72]. - The company sold 198.69 million chicks, with main chicken product revenue accounting for 85.07% of total revenue[72]. - Direct customer sales increased by 13.28% to ¥530,957,198.81, making up 67.59% of total sales[113]. Production and Operational Efficiency - The company aims to enhance management efficiency and optimize talent structure to improve output per unit and drive sustainable development[4]. - The company plans to enhance its core competitiveness through management and technological innovations, aiming for continuous improvement in market share and profitability[18]. - The company intends to implement a standardized operating model of "centralized breeding and decentralized incubation" to reduce expansion costs and diversify its product offerings[18]. - The company has established four high-standard ecological breeding bases and five hatcheries, with a feed processing plant capable of producing 200,000 tons of chicken feed annually[57]. - The company employs a "centralized breeding, decentralized hatching" model to enhance biosecurity and product quality, ensuring efficient operations[59]. - The company has implemented modern production facilities, including advanced air filtration systems and state-of-the-art hatching equipment, ensuring standardized and mechanized operations[90]. Research and Development - The company has filed 6 patents and received 2 authorized patents during the reporting period, along with 2 software copyrights and 2 technology achievement registrations[76]. - The company established the Ningxia Egg Chicken Industry Research Institute to enhance independent innovation capabilities and develop advanced industry technologies[77]. - The research and development team consists of 221 members, accounting for 11.87% of the total workforce, focusing on animal husbandry, veterinary medicine, and animal nutrition[107]. - The company is focusing on technology innovation in areas such as disease prevention, nutrition, and animal welfare, with a commitment to establishing a comprehensive research and development institution[160]. - The company has been recognized as one of the first ten national breeding bases for chicken varieties and has achieved biosecurity certifications from relevant agricultural authorities[162]. Biosecurity and Disease Management - The company has maintained a strong biosecurity system, with no major infectious diseases reported since its establishment, ensuring the health of the chicken population[80]. - The company has invested in biosecurity measures, including the construction of isolation zones in large-scale poultry farms to prevent disease spread[80]. - The company has implemented a comprehensive biosecurity management system, including strict personnel and vehicle entry protocols to minimize disease risks[84]. - The company has established a comprehensive disease prevention system and specific immunization programs, effectively controlling the occurrence and spread of avian influenza through a mandatory vaccination system[99]. - The company has developed a series of integrated disease prevention and purification technologies, including the use of sentinel chickens for monitoring avian diseases, which enhances early detection and response capabilities[100]. Strategic Planning and Future Outlook - The company aims for a sustainable annual sales growth of approximately 20% while maintaining stable cash flow and increasing market share[159]. - Future guidance suggests a revenue growth target of 12% for 2023, driven by both organic growth and acquisitions[183]. - The company plans to invest 50,000,000 CNY in technology upgrades to enhance production efficiency by 20% in the next fiscal year[183]. - A merger with a local competitor is expected to be finalized by the end of Q2 2023, which could potentially increase market penetration by 30%[183]. - The company is exploring potential acquisitions to enhance its supply chain efficiency, with a budget of CNY 100 million allocated for this purpose[199]. Corporate Governance and Management - The governance structure includes a shareholder meeting, board of directors, supervisory board, and senior management, ensuring a coordinated and balanced mechanism for efficient operations[172]. - The company maintains independence from its controlling shareholder in terms of business, personnel, assets, and finance, ensuring no unfair related transactions occur[175]. - The company has established a sound internal management system and independent financial accounting system[178]. - The company actively engages in investor communication through various platforms, including online roadshows and performance briefings[169]. - The company has independent bank accounts and does not share accounts with controlling shareholders or other enterprises[178].